Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $251M Series B ($51M equity + $200M debt) at $800M valuation. 750K customers. $12B moved through platform. Expanding to Canada, UK, Australia in 2026.
Zolve is a cross-border neobank that solves a structural problem in financial services: immigrants arriving in the US have no local credit history, so traditional banks turn them away from credit cards, loans, and even checking accounts. Zolve uses home-country financial data — bank statements, income history, and creditworthiness from the originating country — to underwrite US financial products for new arrivals on day one.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.